Ajuste direto para aquisição de L1066 - LENVATINIB [10 MG; CÁP/ COMP] e L1067 - LENVATINIB [4 MG; CÁP/ COMP] para suprir necessidades na área da saúde.

ID 13362476 · Portal BASE
Price
Base Price
€129,769 .00
Effective Price
€17,695 .00 -86.4%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33600000
Location
Portugal, Lisboa, Lisboa
Bidder Count
—
Winner
EISAI FARMACEUTICA UNIPESSOAL LDA.
NIF 507847660
Company
Dates
Publication
12 Feb 2026
Celebration
12 Feb 2026
Contracting Entity
Centro Hospitalar Universitário Lisboa Central, EPE
NIF 508080142
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 10 · LOW RISK
A9 · Abnormal Price Reduction
A9_PRICE_REDUCTION
LOW
Base price
129769.0
Total effective price
17695.0
Ratio
0.1364
Direction
reduction
Rule
A9 price reduction: ratio 0.1364 outside [0.5, 1.5]
Detected 2026-03-06